Atrial Fibrillation Trial, Recruiting NCT04844944 Sponsor: Helios Health Institute GmbH Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT04844944
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are currently admitted to hospital as an inpatient
  • People who have been diagnosed with at least one of three heart conditions: heart failure, coronary artery disease (a condition where the arteries supplying the heart become narrowed), or atrial fibrillation (an irregular heart rhythm)

Who may not be able to join:

  • People who are unable to give their informed consent to participate in the trial
  • People whose current hospital admission began with a severe state of shock, including cardiogenic shock (when the heart suddenly cannot pump enough blood to the body)
  • People who have previously had a heart transplant, or who currently have a mechanical device implanted to help their heart pump blood

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andreas Bollmann, MD, PhD, Heart Center at University of Leipzig

Phone: +49 341 865-1413

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Helios Health Institute GmbH
Registry
ClinicalTrials.gov
Start date
30 March 2021
Est. completion
1 March 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

All-cause mortality during f/u; All-cause mortality during f/u; All-cause mortality during f/u

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov